Uvox CR 150 is a high-potency controlled-release formulation of fluvoxamine designed to provide consistent and prolonged relief from symptoms associated with various mental health disorders. By selectively inhibiting serotonin reuptake, it helps regulate mood, reduce anxiety, and alleviate compulsive behaviors. This medication is extensively used in the treatment of obsessive-compulsive disorder (OCD), major depressive disorder (MDD), generalized anxiety disorder (GAD), and post-traumatic stress disorder (PTSD), ensuring improved emotional stability and overall mental well-being.

- Sleep & Mental Health > Depression, Anxiety, PTSD Fluvoxamine belongs to the SSRI class and is commonly prescribed for managing mood disorders such as major depressive disorder, generalized anxiety disorder, and PTSD by improving emotional regulation and reducing anxiety symptoms. > Obsessive-Compulsive Disorder (OCD) Approved by the FDA for OCD treatment, fluvoxamine effectively decreases intrusive thoughts and repetitive behaviors by modulating serotonin neurotransmission pathways.

Fluvoxamine increases serotonin levels in the brain by blocking its reabsorption into neurons, thus enhancing neurotransmission balance and promoting mood stabilization. The controlled-release capsule formulation allows for gradual drug release, reducing dosing frequency and minimizing side effects.

Adult Dosage for OCD: - Immediate-release tablets: Start with 50 mg orally once daily at bedtime. - Controlled-release capsules: Begin with 100 mg orally once daily at bedtime. - Maintenance doses range from 100 to 300 mg per day. - Doses exceeding 100 mg should be divided into two administrations, with the larger dose at bedtime. - Dosage can be increased by 50 mg increments every 4 to 7 days, as tolerated. - Maximum dose recommended is 300 mg per day. Pediatric Dosage for OCD: - Children aged 8 to 11 years: Start at 25 mg orally once daily at bedtime; maintenance dose 25-200 mg/day; max 200 mg. - Adolescents aged 11 to 17 years: Start at 25 mg orally once daily at bedtime; maintenance dose 25-300 mg/day; max 300 mg. - Dose increments of 25 mg every 4 to 7 days may be used. - Total daily doses above 50 mg should be split into two doses; larger dose at bedtime. - Female patients might require lower doses for optimal effects.

Store Uvox CR 150 in a cool, dry environment, shielded from direct sunlight and moisture to maintain its stability and potency. Keep in original packaging and out of reach of children.

Common adverse effects may include nausea, headache, dizziness, insomnia, dry mouth, and gastrointestinal discomfort. Sexual dysfunction and appetite changes are also possible. Severe reactions like serotonin syndrome or bleeding are rare but require immediate medical attention. Gradual tapering is recommended to avoid withdrawal symptoms.